The Comorbidities of Epilepsy

Author: Mula, Marco

Brand: Academic Press

Edition: 1

ISBN: 9780128148778

Release Date: 15-05-2019

Languages: English

Binding: paperback

Number Of Pages: 413

Details: Product description Epilepsy is one of most frequent neurological disorders affecting about 50 million people worldwide and 50% of them have at least another medical problem in comorbidity; sometimes this is a the cause of the epilepsy itself or it is due to shared neurobiological links between epilepsy and other medical conditions; other times it is a long-term consequence of the antiepileptic drug treatment. The Comorbidities of Epilepsy offers an up-to-date, comprehensive overview of all comorbidities of epilepsy (somatic, neurological and behavioral), by international authorities in the field of clinical epileptology, with an emphasis on epidemiology, pathophysiology, diagnosis and management. This book includes also a critical appraisal of the methodological aspects and limitations of current research on this field. Pharmacological issues in the management of comorbidities are discussed, providing information on drug dosages, side effects and interactions, in order to enable the reader to manage these patients safely. The Comorbidities of Epilepsy is aimed at all health professionals dealing with people with epilepsy including neurologists, epileptologists, psychiatrists, clinical psychologists, epilepsy specialist nurses and clinical researchers. Review Comprehensive review of all comorbidities of epilepsy, covering epidemiology, pathophysiology and clinical management From the Back Cover The Comorbidities of Epilepsy Edited by Marco Mula Epilepsy is one of most frequent neurological disorders affecting about 50 million people worldwide and 50% of them have at least another medical problem in comorbidity; sometimes this is a the cause of the epilepsy itself or it is due to shared neurobiological links between epilepsy and other medical conditions; other times it is a long-term consequence of the antiepileptic drug treatment. The Comorbidities of Epilepsy offers an up-to-date, comprehensive overview of all comorbidities of epilepsy (somatic, neurological and behavioral), by international authorities in the field of clinical epileptology, with an emphasis on epidemiology, pathophysiology, diagnosis and management. This book includes also a critical appraisal of the methodological aspects and limitations of current research on this field. Pharmacological issues in the management of comorbidities are discussed, providing information on drug dosages, side effects and interactions, in order to enable the reader to manage these patients safely. The Comorbidities of Epilepsy is aimed at all health professionals dealing with people with epilepsy including neurologists, epileptologists, psychiatrists, clinical psychologists, epilepsy specialist nurses and clinical researchers. Key Features: Provides a comprehensive overview of somatic, neurological and behavioral co-morbidities of epilepsy Discusses up-to-date management of comorbidities of epilepsy Written by a group of international experts in the field About the Editor: Marco Mula, MD, PhD, is Consultant in Neurology and Epileptology at the Atkinson Morley Regional Neuroscience Centre, St. George’s University Hospitals NHS Foundation Trust and Reader in Neurology at St. George’s University of London. Dr Mula is currently Chair of the International League Against Epilepsy (ILAE) Task Force on Identification Treatment and Prevention of the Commission on Psychiatry and member of the ILAE Task Force on Paediatric Psychiatric Issues. He has authored almost 200 publications in the field of epilepsy treatment and the management of comorbidities of epilepsy with special reference to behavioural problems. About the Author Marco Mula, MD, PhD, is Consultant in Neurology and Epileptology at the Atkinson Morley Regional Neuroscience Centre, St. George’s University Hospitals NHS Foundation Trust and Reader in Neurology at St. George’s University of London. Dr Mula is currently Chair of the International League Against Epilepsy (ILAE) Task Force on Identification Treatment and Prevention of